Human platelets contain p110delta phosphoinositide 3-kinase

Area of Science:

• Biochemistry
• Cell Biology
• Hematology

Background:

• Phosphoinositide 3-kinase (PI3K) catalytic subunit p110delta is primarily found in leukocytes.
• Previous research indicated its absence in platelets, a key component of the leukocyte family.
• Platelets are crucial for hemostasis and immune response, making their molecular composition of significant interest.

Purpose of the Study:

• To investigate the presence and localization of PI3K catalytic subunit p110delta in human platelets.
• To determine if p110delta associates with known regulatory subunits (p85alpha, p85beta) in platelets.
• To explore the potential role of p110delta in platelet cytoskeletal function.

Main Methods:

• Western blotting using p110delta-specific antibodies.
• Reverse transcription-polymerase chain reaction (RT-PCR) to detect p110delta mRNA.
• PI3K activity assays to measure enzyme function.
• Immunoprecipitation of PI3K Class IA subunits (p85alpha, p85beta, p110delta).
• Analysis of cytosolic and cytoskeletal fractions from resting and activated platelets.

Main Results:

• PI3K catalytic subunit p110delta was detected in human platelets.
• p110delta was found to associate with both p85alpha and p85beta regulatory subunits.
• The enzyme was identified in both cytosolic and cytoskeletal fractions of platelets.
• Presence in the cytoskeletal fraction was observed in both resting and thrombin receptor-activated platelets.

Conclusions:

• The phosphoinositide 3-kinase (PI3K) catalytic subunit p110delta is present in human platelets.
• p110delta forms a complex with p85alpha and p85beta in platelets.
• The association of p110delta with the platelet cytoskeleton supports its proposed role in cytoskeletal regulation.